Apply Now Download Brochure Call Us Events Chat with Ambassador

      +1 (396) 486 4709

      Deepak Kumar

      Deepak Kumar
      Deepak Kumar

      Professor

      PhD (South Korea), Alumnus (Sikkim Central University, Uttar Pradesh Technical University, Lucknow)

      Deepak Kumar is a Professor and Dean, School of Pharmaceutical Sciences at Shoolini University. He also holds several strategic leadership roles, including Chief Coordinator, E-YUVA Centre (supported by DBT–BIRAC, Government of India); Coordinator, iHUB Shoolini (supported by iHUB DivyaSampark, a Technology Innovation Hub jointly supported by DST, Government of India, and IIT Roorkee); and Institutional Representative for I-STEM (Indian Science, Technology and Engineering Facilities Map), Government of India. In addition, he serves as an Innovation Ambassador under the Ministry of Education (Innovation Cell) and AICTE, Government of India. 

      Prof Kumar completed his PhD and Postdoctoral research in South Korea under the prestigious Brain Korea 21 Plus (BK21+) Fellowship. He holds an M Pharm from Sikkim Central University and a B Pharm from Uttar Pradesh Technical University, Lucknow. His academic and research career reflects strong global exposure and sustained excellence in pharmaceutical sciences. 

      For the past four consecutive years, Prof Kumar has been recognised among the World’s Top 2% Scientists by Stanford University and Elsevier, underscoring his global research impact. He has authored 180+ research papers in high-impact SCI-indexed journals, filed 50+ patents with 8 granted, contributed 30+ book chapters, and edited and authored over three books published by leading international publishers such as ACS, Elsevier, Springer Nature, Taylor & Francis, and Wiley. He also serves as an editor and reviewer for several reputed international scientific journals. 

      Prof Kumar has secured over ₹5 crore in research funding from national agencies including DST, DBT, BIRAC, and MSME. His recent work includes a publication in the prestigious Nature journal Signal Transduction and Targeted Therapy (Impact Factor: 52.7). His current research metrics include an h-index of 44+, i10-index of 144+, and 7,000+ citations. 

      A sought-after academic voice, Prof Kumar has been invited as a chairperson, keynote speaker, and session speaker at leading national and international conferences across the UK, China, Hong Kong, Taiwan, Thailand, Uzbekistan, Kazakhstan, and South Korea. His contributions have earned him numerous accolades, including the High Impact Factor Research Award (2022) conferred by the Hon’ble Governor of Himachal Pradesh, Research Excellence Awards (2019–2024), Leading Patent Filers Awards (2023, 2024), Nature Journal Award (2023), Top 10 Patent Filers Award (2022), International Scientist Award (2021), Young Scientist Award (2020), Innovative Research Award (2019), Young Investigator Award (2016), and the BK21 Plus Travel Grant for the Gordon Research Conference, South Korea. 

      He has successfully supervised 8+ PhD scholars, 2 Postdoctoral fellows, and 50+ Master’s students. He maintains strong industry and academic collaborations, with multiple technology transfers, MoUs with leading industries, institutes of national importance, and international universities. 

      He is an active member of several prestigious professional bodies, including the Association of Pharmacy Professionals (APP), Association of Pharmaceutical Teachers of India (APTI), Indian Pharmacy Graduates Association (IPGA), Society of Biological Chemists (India), Society for Plant Research, Indian Society of Cell Biology, Society for Biotechnologists (India), Chemical Research Society of India (CRSI), Society for Ethnopharmacology, and the American Chemical Society, among others in India and South Korea. 

       

      His research interests include Medicinal Chemistry and Drug Discovery, Bioinformatics, Bioorganic Chemistry, Drug Delivery Systems, Nanomedicine and smart drug-delivery platforms, Chemical Biology, Natural Products synthesis and formulation, Diversity-Oriented Synthesis, and the development of novel small molecules for cancer, type II diabetes, and antimicrobial applications.

      Publications

      1. A. Kumar, B. Singh, S. Sengupta, P. Singh, M. Ghate, A.K. Yadav, M. Garg, D. Kumar, Design and synthesis of 2-substituted phenyl-4,5-diphenyl imidazole linked benzotriazoles: Anti-breast cancer activity, cell cycle analysis, apoptosis assay, and in silico studies, Journal of Molecular Structure, 2026, Elsevier Ltd. 
      2. A. Kumar, S. Sengupta, A. K. Yadav, R. P. Singh, T. Sinha, P. Bhattacharjee, B. Basu, G. Marriapan, S. Bhattacharyya, D. Kumar, Design, synthesis, anti-breast cancer and in silico studies of substituted triphenyl imidazole-N-alkyl linked indole derivatives, Future Medicinal Chemistry, 2025, 17(14), 1675–1692. Taylor and Francis Group. 
      3. V. Panwar, Y. Rohila, A. Singh, B. Meenakshi, Singh, M.K. Gupta, M. Garg, D. Kumar, Design, synthesis, in silico, anticancer evaluations of N-acylhydrazone derivatives as STAT3 inhibitors, Future Medicinal Chemistry, 2025, 17(13), 1509–1519. Taylor and Francis Group. 
      4. R. Poria, A. Kaushal, S. Verma, S.K. Ramasamy, G.S. Ghodake, Deepak Kumar, S. Gupta, GQD/g-C3N4-modified nanochip for electrochemical detection of Dengue serotype 3. Analyst, 2025, Royal Society of Chemistry. 
      5. D. Lutomia, R. Poria, D. Kala, A.K. Singh, M.K. Gupta, Deepak Kumar, A. Kaushal, S. Gupta, Unlocking the Potential of 2D Nanomaterials with biosensors in biomarker-based detection of Helicobacter pylori. Materials Advances, 2025, 6, 117. Royal Society of Chemistry. 
      6. A. Kumar, A. Kaushal, P.K. Verma, M.K. Gupta, G. Chandra, U. Kumar, A.K. Yadav, Deepak Kumar, An insight into recent developments in imidazole based heterocyclic compounds as anticancer agents: Synthesis, SARs, and mechanism of actions, European Journal of Medicinal Chemistry, 2024, 116896, Elsevier Ltd. 
      7. S.R. Gopireddy, V. Panwar, A. Sarkar, M. Jain, K.B. Tejaswini, K.B. Chandrasekhar, Deepak Kumar, Evaluation and Docking Studies of Disubstituted N‐Heterocyclic Derivatives as Anticancer Agents. Chemistry & Biodiversity, 2024,e202401010, John Wiley & Sons, Ltd. 
      8. S. Sebastian, Y. Rohila, Meenakshi., A. Ansari, S. Sengupta, Deepak Kumar, N. Srivastava, L. Kumar, M.K. Gupta, Anti-quorum sensing activity of α-amidoamides against Agrobacterium tumefaciensNT1: Insights from molecular docking and dynamic investigations to synergistic approach of metronidazole release from gel formulation, Microbial Pathogenesis, 2024,193,106787, Elsevier Ltd. 
      9. S. Sebastian, Y. Rohila, Meenakshi., S. Prakash, A. Kumar, S. Sengupta, Deepak Kumar, A. Ansari, M.K. Gupta, Atom-economical synthesis, antimicrobial assessment, and molecular dynamics of indole-derived peptidomimetics for improved therapeutic insights, Journal of Molecular Structure, 2024,1318,139211, Elsevier Ltd. 
      10. M.K. Shukla, H. Kaushik, H. Tiwari, C. Behera, R.K. Tonk, A. Husain, J. Singh, K. Kesari, Deepak Kumar, Development and characterization of Myrica esculenta plant extract-based albumin  nanoparticles for anticancer activity, Industrial Crops and Products, 2024, 218,118815, Elsevier Ltd. 
      11. S. Kumar, I. Ali, F. Abbas, F. Shafiq, A.K. Yadav, Ghate. M., Deepak Kumar, In-silico identification and exploration of small molecule coumarin-1, 2, 3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer, Molecular Diversity, 2024, 1-24, Springer Nature Switzerland AG. 
      12. Y. Rohila, S. Sebastian, A. Ansari, Deepak Kumar, D.K. Mishra, M.K. Gupta, A Comprehensive Review of the Diverse Spectrum Activity of 1, 2, 3‐Triazole‐linked Isatin Hybrids, Chemistry & Biodiversity. 2024, 4, e202301612, Wiley. 
      13. R. Verma, S.K. Yadav, R. Singh, K.R.B. Verma, Deepak Kumar, J. Singh, Laccase- Conjugated Nanostructured ZnFe2O4/rgo-Modified Electrode -Based Interfaces for Electrochemical Impedance Monitoring of Adrenaline: A Promising Biosensor for Management, ACS Appl. Bio Mater. 2023, 6(12), 5842-53. American Chemical Society 
      14. V. Panwar, A. Singh, M. Bhatt, R.K. Tonk, S. Azizov, A.S. Raza, S. Sengupta, Deepak Kumar, M. Garg,Multifaceted role of mTOR( mammalian target of rapamycin) signaling pathway in human health and disease,Nature-Signal Transduction and Targeted Therapy, 2023, 8, 375. Nature Publisher 
      15. S. Sebastian, E. Yadav, P. Bhardwaj, M. Maruthi, Deepak Kumar, M.K. Gupta, Facile one-pot multicomponent synthesis of peptoid based gelators as novel scaffolds for drug incorporation and Ph –sensitive release, Journal of Materials Chemistry B, 2023, 11(41), 9975. Royal Society of Chemistry. 
      16. M. Kausar, P. Pandey, D. Bishta, S. Sengupta, Deepak Kumar, In-silico anti-vitiligo activity of glycyrrhizin as potential IL-17 inhibitor and in-vitro antioxidant potential of isolated glycyrrhizin from G. glabra, South African Journal of Botany, 2023 ,162,381-90, Elsevier Ltd. 
      17. A. Kaushal, J. Bhukya, A.K. Yadav, V. Mishra, Deepak Kumar, In(III)- catalyzed C3-alkylation of indoles with 2H-chromen-2-ol derivatives,Tetrahedron Letters, 2023, 129,154742. Elsevier Ltd. 
      18. S. Kumar, I. Ali, F. Abbas, A. Rana, S. Pandey, M. Garg, Deepak Kumar In-silico design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1, 2, 3-triazole hybrids as novel EGFR inhibitors targeting lung cancer, Journal of Biomolecular Structure and Dynamics, 2024, 42(18), 9416-38.Taylor and Francis Group. 
      19. M. Shukla, A. Parihar, C. Karththikeyan, Deepak Kumar, R. Khan, Multifunctional GQDs for receptor targeting, drug delivery, and bioimaging in pancreatic cancer, Nanoscale, 2023,15(36),14698-716. Royal Society of Chemistry. 
      20. L. Kumar, M. Bisen, K. Harjai, S. Chhibber, S. Azizov, H. Lalhlenmawia, Deepak Kumar, Advances in nanotechnology for biofilm inhibition, ACS omega. 2023 ,8(24), 21391-409, American Chemical Society. 
      21. S. Kumar, S. Sengupta, I. Ali, M.K. Gupta,H.Lalhlenmawia, S. Azizov, Deepak Kumar,  Identification and exploration of quinazoline-1, 2, 3-triazole inhibitors targeting EGFR in lung cancer, Journal of Biomolecular Structure and Dynamics. 2023 ,41(21),11353-72, Taylor and Francis Group 
      22. A. Kumar, C. Vigato, D. Boschi, M.L. Lolli, Deepak Kumar, Phenothiazines as anti-cancer agents :SAR overview and synthetic strategies, European Journal of Medicinal Chemistry, 2023, 254,115337, Elsevier Ltd. 
      23. A. Sharma, D. Shambhwani, J. Singh, H. Lalhlenmawia, M. Kumarasamy, S.K. Singh, Deepak Kumar, Advances in lung cancer treatment using nanomedicines, ACS omega, 2023 ,8(1),10-41. American Chemical Society. 
      24. A Sharma, R Nagraik, B Venkidasamy, A Khan, K Dulta, P.K Chauhan, Deepak Kumar, D.S. Shin, n vitro antidiabetic, antioxidant, antimicrobial, and cytotoxic activity of Murraya koenigii leaf extract intercedes ZnO nanoparticles, Luminescence, 2023 , 38(7),1139-48, wiley 
      25. A. Sharma, A. Kumar, S. Pandey, Deepak Kumar, Importance of photophosphatidylserine and Tim-3 in photoimmunotherapy, RSC Medicinal Chemistry, 2022, 13, 11, 1274-1275, Royal Society of Chemistry.  
      26. A. Sharma, R. Nagraik, S. Sharma, G. Sharma, S. Pandey, S. Azizov, P.K. Chauhan, Deepak Kumar, Green synthesis of ZnO nanoparticles using Ficus palmata: Antioxidant, antibacterial and antidiabetic studies, Results in Chemistry, 2022, 4, 100509. Elsevier Ltd. 
      27. Arjun Attri, Deepak Thakur, Taranpreet Kaur, Sebstian Sensale, Zhangli Peng, Deepak Kumar, Ramanpreet Singh, Nanoparticles Incorporating a Fluorescence Turn-on Reporter for Real-Time Drug Release Monitoring, a Chemoenhancer and a Stealth Agent: Poseidon’s Trident against Cancer?, Molecular Pharmaceutics, 2021, 18, 124 – 147, ACS Publication 
      28. A. K. Dash, Debraj Mukherjee, A. Dhulap, S. Haider, Deepak Kumar*, Green chemistry appended synthesis, metabolic stability and pharmacokinetic assessment of medicinally important chromene dihydro pyrimidinones. Bioorganic & Medicinal Chemistry Letters. 2019. 29 (24): 126750-126754. Elsevier Ltd. 
      29.  
      30. Deepak Kumar, G. Mariappan, A. Husain, J. Monga, S. Kumar. Design, synthesis and cytotoxic evaluation of novel imidazolone fused quinazolinone derivatives. Arabian Journal of Chemistry. 2017. 10(3): 344-350. Elsevier Ltd.
      Search Program
      Admissions Open 2026-27
      Apply Now
      Shoolini University
      Shoolini University
      Shoolini University

      4th Year in a Row

      Information About
        Information For
          Quick Links
            Contact

            City Office

            Address

            Mailing Address:

            Copyright ©2025 Shoolini Foundation of Life Sciences and Business Management

            Enquire Now